P2X7 receptor polymorphisms do not influence endothelial function and vascular tone in neo-diagnosed, treatment-naive essential hypertensive patients

Journal of Hypertension

Volumn 31, Issue 12, 2013, Pages 2362-2369

  Ghiadoni, Lorenzo ^a   Rossi, Chiara ^a   Duranti, Emiliano ^a   Santini, Eleonora ^a   Bruno, Rosa Maria ^a   Salvati, Antonio ^a   Taddei, Stefano ^a   Solini, Anna ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

arterial stiffness; endothelial function; hypertension; oxidative stress; P2X7 receptor

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; PURINERGIC P2X7 RECEPTOR; THIOBARBITURIC ACID; TRIACYLGLYCEROL; URIC ACID;

ADULT; AORTIC PULSE WAVE VELOCITY; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; BLOOD VESSEL FUNCTION; BLOOD VESSEL PARAMETERS; BLOOD VESSEL TONE; BRACHIAL ARTERY FLOW MEDIATED DILATATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ECHOGRAPH; ENDOTHELIAL FUNCTION; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENE MUTATION; HOMOZYGOSITY; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PULSE WAVE; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SPECTROPHOTOMETER; TONOMETER; TONOMETRY; VASCULAR ENDOTHELIUM;

ADULT; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MUSCLE TONUS; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, PURINERGIC P2X7;

EID: 84888091690     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283653ff5     Document Type: Article

References (38)

1. Sudano I, Roas S, Noll G. Vascular abnormalities in essential hypertension. Curr Pharm Des 2011; 17:3039-3044.
2. Vanhoutte PM, Shimokawa H, Tang EH, Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 2009; 196:193-222.
3. Schulz E, Gori T, Münzel T. Oxidative stress and endothelial dysfunction in hypertension. Hypertens Res 2011; 34:665-673.
4. Kawano N, Emoto M, Mori K, Yamazaki Y, Urata H, Tsuchikura S, et al. Association of endothelial and vascular smooth muscle dysfunction with cardiovascular risk factors, vascular complications, and subclinical carotid atherosclerosis in type 2 diabetic patients. J Atheroscler Thromb 2012; 19:276-284.
5. Vaidya D, Szklo M, Cushman M, Holvoet P, Polak J, Bahrami H, et al. Association of endothelial and oxidative stress with metabolic syndrome and subclinical atherosclerosis: multiethnic study of atherosclerosis. Eur J Clin Nutr 2011; 65:818-825.
6. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55:1318-1327.
7. Lacolley P, Challande P, Osborne-Pellegrin M, Regnault V. Genetics and pathophysiology of arterial stiffness. Cardiovasc Res 2009; 81:637-648.
8. Simino J, Shi G, Kume R, Schwander K, Province MA, Gu CC, et al. Five blood pressure loci identified by an updated genome-wide linkage scan: metaanalysis of the Family Blood Pressure Program. Am J Hypertens 2011; 24:347-354.
9. Burnstock G, Kennedy C. P2X receptors in health and disease. Adv Pharmacol 2011; 61:333-372.
10. Cesaro A, Brest P, Hofman V, Hébuterne X, Wildman S, Ferrua B, et al. Amplification loop of the inflammatory process is induced by P2X7R activation in intestinal epithelial cells in response to neutrophil transepithelial migration. Am J Physiol Gastrointest Liver Physiol 2010; 299:G32-G42.
11. Madec S, Rossi C, Chiarugi M, Santini E, Salvati A, Ferrannini E, Solini A. Adipocyte P2X7 receptors expression: a role in modulating inflammatory response in subjects with metabolic syndrome? Atherosclerosis 2011; 219:552-558.
12. Solini A, Cuccato S, Ferrari D, Santini E, Gulinelli S, Callegari MG, et al. Increased P2X7 receptor expression and function in thyroid papillary cancer: a new potential marker of the disease? Endocrinology 2008; 149:389-396.
13. Chiao CW, Tostes RC, Webb RC. P2X7 receptor activation amplifies lipopolysaccharide-induced vascular hyporeactivity via interleukin-1 beta release. J Pharmacol Exp Ther 2008; 326:864-870.
14. Liu C, Mather S, Huang Y, Garland CJ, Yao X. Extracellular ATP facilitates flow-induced vasodilatation in rat small mesenteric arteries. Am J Physiol Heart Circ Physiol 2004; 286:H1688-H1695.
15. Ji X, Naito Y, Hirokawa G, Weng H, Hiura Y, Takahashi R, Iwai N. P2X(7) receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats. Hypertens Res 2012; 35:173-179.
16. Chatterjee S, Rana R, Corbett J, Kadiiska MB, Goldstein J, Mason RP. P2X7 receptor-NADPH oxidase axis mediates protein radical formation and Kupffer cell activation in carbon tetrachloride-mediated steatohepatitis in obese mice. Free Radic Biol Med 2012; 52:1666-1679.
17. Portales-Cervantes L, Niño-Moreno P, Salgado-Bustamante M, García-Hernández MH, Baranda-Candido L, Reynaga-Hernández E, et al. The His155Tyr (489C T) single nucleotide polymorphism of P2RX7 gene confers an enhanced function of P2X7 receptor in immune cells from patients with rheumatoid arthritis. Cell Immunol 2012; 276:168-175.
18. Wesselius A, Bours MJ, Arts IC, Theunisz EH, Geusens P, Dagnelie PC. The P2X7 loss-of-function Glu496Ala polymorphism affects ex vivo cytokine release and protects against the cytotoxic effects of high ATP levels. BMC Immunol 2012; 13:64.
19. Palomino-Doza J, Rahman TJ, Avery PJ, Mayosi BM, Farrall M, Watkins H, et al. Ambulatory blood pressure is associated with polymorphic variation in P2X receptor genes. Hypertension 2008; 52:980-985.
20. Gidlöf O, Smith JG, Melander O, Lövkvist H, Hedblad B, Engström G, et al. A common missense variant in the ATP receptor P2X7 is associated with reduced risk of cardiovascular events. PLoS One 2012; 7:e37491.
21. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germanò G, et al. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187.
22. Ghiadoni L, Magagna A, Versari D, Kardasz I, Huang Y, Taddei S, Salvetti A. Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 2003; 41:1281-1286.
23. Gemignani V, Faita F, Ghiadoni L, Poggianti E, Demi M. A system for real-time measurement of the brachial artery diameter in B-mode ultrasound images. IEEE Trans Med Imaging 2007; 26:393-404.
24. Gemignani V, Bianchini E, Faita F, Giannarelli C, Ghiadoni L, Demi M. Ultrasound measurement of the brachial artery flow-mediated dilation without ECG gating. Ultrasound Med Biol 2008; 34:385-391.
25. Ghiadoni L, Faita F, Salvetti M, Cordiano C, Biggi A, Puato M, et al. Assessment of flow-mediated dilation reproducibility: a nationwide multicenter study. J Hypertens 2012; 30:1399-1405.
26. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588-2605.
27. Plantinga Y, Ghiadoni L, Magagna A, Giannarelli C, Franzoni F, Taddei S, Salvetti A. Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens 2007; 20:392-397.
28. Kiefmann R, Islam MN, Lindert J, Parthasarathi K, Bhattacharya J. Paracrine purinergic signaling determines lung endothelial nitric oxide production. Am J Physiol Lung Cell Mol Physiol 2009; 296:L901-L910.
29. Shen J, DiCorleto PE. ADP stimulates human endothelial cell migration via P2Y1 nucleotide receptor-mediated mitogen-activated protein kinase pathways. Circ Res 2008; 102:448-456.
30. Jackson SW, Hoshi T, Wu Y, Sun X, Enjyoji K, Cszimadia E, et al. Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice. Am J Pathol 2007; 171:1395-1404.
31. Xiao J, Sun L, Yan H, Jiao W, Miao Q, Feng W, et al. Metaanalysis of P2X7 gene polymorphisms and tuberculosis susceptibility. FEMS Immunol Med Microbiol 2010; 60:165-170.
32. Sluyter R, Stokes L, Fuller SJ, Skarratt KK, Gu BJ, Wiley JS. Functional significance of P2RX7 polymorphisms associated with affective mood disorders. J Psychiatr Res 2010; 44:1116-1117.
33. Sorge RE, Trang T, Dorfman R, Smith SB, Beggs S, Ritchie J, et al. Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity. Nat Med 2012; 18:595-599.
34. Hill LM, Gavala ML, Lenertz LY, Bertics PJ. Extracellular ATP may contribute to tissue repair by rapidly stimulating purinergic receptor X7-dependent vascular endothelial growth factor release from primary human monocytes. J Immunol 2010; 185:3028-3034.
35. Placido R, Auricchio G, Falzoni S, Battistini L, Colizzi V, Brunetti E, et al. P2X(7) purinergic receptors and extracellular ATP mediate apoptosis of human monocytes/macrophages infected with Mycobacterium tuberculosis reducing the intracellular bacterial viability. Cell Immunol 2006; 244:10-18.
36. Di Virgilio F. Purines, purinergic receptors, and cancer. Cancer Res 2012; 72:5441-5447.
37. García-Hernández MH, Portales-Cervantes L, Cortez-Espinosa N, Vargas-Morales JM, Fritche Salazar JF, Rivera-López E, et al. Expression and function of P2X(7) receptor and CD39/Entpd1 in patients with type 2 diabetes and their association with biochemical parameters. Cell Immunol 2011; 269:135-143.
38. Sun S, Xia S, Ji Y, Kersten S, Qi L. The ATP-P2X7 signaling axis is dispensable for obesity-associated inflammasome activation in adipose tissue. Diabetes 2012; 61:1471-1478.